Neuromuscular ultrasound for taxane peripheral neuropathy in breast cancer

Our study aim was to evaluate neuromuscular ultrasound (NMUS) for the assessment of taxane chemotherapy‐induced peripheral neuropathy (CIPN), the dose‐limiting toxicity of this agent.

[1]  S. Barnes,et al.  Clinical and research applications of neuromuscular ultrasound in amyotrophic lateral sclerosis , 2019, Degenerative neurological and neuromuscular disease.

[2]  G. Nicolini,et al.  Chemotherapy-Induced Peripheral Neuropathy and Changes in Cytoskeleton , 2019, International journal of molecular sciences.

[3]  L. Pelosi,et al.  Nerve ultrasound as a diagnostic tool for sensory neuronopathy in spinocerebellar ataxia syndrome , 2019, Clinical Neurophysiology.

[4]  R. Gold,et al.  Prospective Study of the Clinical, Electrophysiologic, and Sonographic Characteristics of Oxaliplatin‐Induced Neuropathy , 2018, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[5]  L. Pelosi,et al.  Peripheral nerves are pathologically small in cerebellar ataxia neuropathy vestibular areflexia syndrome: a controlled ultrasound study , 2018, European journal of neurology.

[6]  S. Hovius,et al.  Ultrasound assessment of the sural nerve in patients with neuropathic pain after ankle surgery , 2018, Muscle & nerve.

[7]  L. Pelosi,et al.  Neuronopathy and neuropathy in autosomal dominant spino-cerebellar ataxia (SCA): A preliminary peripheral nerve ultrasound study , 2017, Clinical Neurophysiology.

[8]  F. Walker,et al.  Ultrahigh‐frequency ultrasound of fascicles in the median nerve at the wrist , 2017, Muscle & nerve.

[9]  L. Pelosi,et al.  Peripheral nerve ultrasound in cerebellar ataxia neuropathy vestibular areflexia syndrome (CANVAS) , 2017, Muscle & nerve.

[10]  F. Horak,et al.  Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  H. Ebadi,et al.  Peripheral nerve high‐resolution ultrasound in diabetes , 2017, Muscle & nerve.

[12]  R. Buschbacher,et al.  Electrodiagnostic reference values for upper and lower limb nerve conduction studies in adult populations , 2016, Muscle & nerve.

[13]  P. Dougherty,et al.  Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy. , 2016, The journal of pain : official journal of the American Pain Society.

[14]  M. Cartwright,et al.  Neuromuscular Ultrasound in the Assessment of Polyneuropathies and Motor Neuron Disease. , 2016, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[15]  P. Fuhr,et al.  The Ultrasound pattern sum score – UPSS. A new method to differentiate acute and subacute neuropathies using ultrasound of the peripheral nerves , 2015, Clinical Neurophysiology.

[16]  H. Ebadi,et al.  Peripheral Nerve Ultrasound in Small Fiber Polyneuropathy. , 2015, Ultrasound in medicine & biology.

[17]  G. Nicolini,et al.  Axonal Transport Impairment in Chemotherapy-Induced Peripheral Neuropathy , 2015, Toxics.

[18]  H. Heinze,et al.  Peripheral nerve ultrasound in amyotrophic lateral sclerosis phenotypes , 2015, Muscle & nerve.

[19]  Aanem.  Proper Performance and Interpretation of Electrodiagnostic Studies. [Corrected]. , 2015, Muscle & nerve.

[20]  M. Ewertz,et al.  Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors. , 2015, European journal of cancer.

[21]  A. Pestronk,et al.  Nerve size in chronic inflammatory demyelinating neuropathy varies with disease activity and therapy response over time: A retrospective ultrasound study , 2014, Muscle & nerve.

[22]  S. Sindrup,et al.  Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies , 2014, European journal of neurology.

[23]  M. Koltzenburg,et al.  Chemotherapy‐induced peripheral neurotoxicity: A critical analysis , 2013, CA: a cancer journal for clinicians.

[24]  F. Walker,et al.  Neuromuscular ultrasound in common entrapment neuropathies , 2013, Muscle & nerve.

[25]  L. Deangelis,et al.  Electrophysiological Features of Taxane-Induced Polyneuropathy in Patients With Breast Cancer , 2013, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[26]  N. Aaronson,et al.  Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire , 2013, Quality of Life Research.

[27]  C. Tempelmann,et al.  Sonography of the median nerve in CMT1A, CMT2A, CMTX, and HNPP , 2013, Muscle & nerve.

[28]  L. Padua,et al.  Ultrasound assessment of oxaliplatin‐induced neuropathy and correlations with neurophysiologic findings , 2013, European journal of neurology.

[29]  P. Novotny,et al.  Further data supporting that paclitaxel‐associated acute pain syndrome is associated with development of peripheral neuropathy , 2012, Cancer.

[30]  J. Goodwin,et al.  Decline in the use of anthracyclines for breast cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  P. Milani,et al.  Taxane-induced peripheral neuropathy has good long-term prognosis: a 1- to 13-year evaluation , 2012, Journal of Neurology.

[32]  F. Walker,et al.  Peripheral nerve and muscle ultrasound in amyotrophic lateral sclerosis , 2011, Muscle & nerve.

[33]  Antai Wang,et al.  Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy , 2011, Breast Cancer Research and Treatment.

[34]  A. Pestronk,et al.  Peripheral nerve size in normals and patients with polyneuropathy: An ultrasound study , 2009, Muscle & nerve.

[35]  M. Benatar,et al.  Reference data for commonly used sensory and motor nerve conduction studies , 2009, Muscle & nerve.

[36]  F. Walker,et al.  Diagnostic nerve ultrasound in Charcot–Marie–Tooth disease type 1B , 2009, Muscle & nerve.

[37]  F. Walker,et al.  Cross‐sectional area reference values for nerve ultrasonography , 2008, Muscle & nerve.

[38]  Giuseppe Lauria,et al.  Skin biopsy as a diagnostic tool in peripheral neuropathy , 2007, Nature Clinical Practice Neurology.

[39]  A. Windebank,et al.  Paclitaxel toxicity in post-mitotic dorsal root ganglion (DRG) cells. , 2006, Anticancer research.

[40]  L. H. van den Berg,et al.  Ultrasonography shows extensive nerve enlargements in multifocal motor neuropathy , 2005, Neurology.

[41]  J. McArthur,et al.  Epidermal nerve fiber density: normative reference range and diagnostic efficiency. , 1998, Archives of neurology.

[42]  D A Berry,et al.  Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. , 1998, Journal of the National Cancer Institute.

[43]  L. Deangelis,et al.  Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing , 1997, Journal of Neuro-Oncology.

[44]  R. Donehower,et al.  Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies , 1994, Annals of neurology.